EP Patent

EP1654004A2 — Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides

Assigned to Novo Nordisk AS · Expires 2006-05-10 · 20y expired

What this patent protects

The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein.

USPTO Abstract

The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein.

Drugs covered by this patent

Patent Metadata

Patent number
EP1654004A2
Jurisdiction
EP
Classification
—
Expires
2006-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.